✦ LIBER ✦

Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study

✍ Scribed by Paul Kah Hing Ling; Fernando Civeira; Andrei Gheorghe Dan; Mary E Hanson; Rachid Massaad; Celine Le Bailly De Tilleghem; Christopher Milardo; Joseph Triscari

Book ID: 115020479
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 158 KB
Volume: 11
Category: Article
ISSN: 1476-511X
DOI: 10.1186/1476-511x-11-18

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

87 EZETIMIBE/SIMVASTATIN 10/40MG VERSUS

87 EZETIMIBE/SIMVASTATIN 10/40MG VERSUS ATORVASTATIN 40MG IN HIGH CARDIOVASCULAR RISK PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, MULTICENTER STUDY

✍ Civeira, F.; Dan, A.G.; Hing, P.L.K.; Hanson, M.E.; Massaad, R.; Milardo, C.; Tr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Ezetimibe/Simvastatin 10/40 mg Versus At

Ezetimibe/Simvastatin 10/40 mg Versus Atorvastatin 40 mg in High Cardiovascular Risk Patients with Primary Hypercholesterolemia

✍ Joseph Triscari; Fernando Civeira; Andrei Gheorghe Dan; Paul Kah-Hing Ling; Mary 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 41 KB